RenovaCare, Inc.
OTC: RCAR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Harmel Singh Rayat
- Employees
- 1
- Headquarters
- Scottsdale, United States
- IPO year
- 1996
- Market cap
- $8.7K
- Website
- https://www.renovacareinc.com
Loading RCAR…
Loading profile data…Frequently asked questions about RCAR
What does RenovaCare, Inc. (RCAR) do?
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a...
Where does RCAR trade?
RenovaCare, Inc. (RCAR) trades on the Other OTC.
What sector is RCAR in?
RenovaCare, Inc. (RCAR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RenovaCare, Inc.?
Harmel Singh Rayat is the chief executive officer of RenovaCare, Inc. (RCAR).
Where is RenovaCare, Inc. headquartered?
RenovaCare, Inc. is headquartered in United States.
Does RCAR pay a dividend?
RenovaCare, Inc. (RCAR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RCAR go public?
RenovaCare, Inc. (RCAR) completed its initial public offering in 1996.